Sale!

Endomysial Antibody IgA IFA in Dilutions Test

Original price was: $188.Current price is: $126.

-33%

The Endomysial Antibody IgA IFA in Dilutions Test is a specialized diagnostic tool used to detect autoimmune antibodies associated with celiac disease. This advanced immunofluorescence assay measures IgA antibodies targeting endomysial tissue, providing crucial information for diagnosing gluten-sensitive enteropathy. The test is particularly valuable for patients experiencing chronic gastrointestinal symptoms, unexplained weight loss, or nutritional deficiencies. With results available the next day and a discounted price of $126 USD (regularly $188), this test offers accessible diagnostic insights. Our nationwide network ensures convenient testing across major US cities, supported by expert gastroenterological interpretation and comprehensive patient care.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

Endomysial Antibody IgA IFA in Dilutions Test

Understanding the Endomysial Antibody Test

The Endomysial Antibody IgA IFA in Dilutions Test represents a cornerstone in autoimmune gastrointestinal diagnostics, specifically designed to detect celiac disease with exceptional accuracy. This sophisticated immunofluorescence assay identifies IgA-class antibodies that target the endomysium—the connective tissue surrounding muscle fibers in the small intestine. When these antibodies are present, they indicate an autoimmune response to gluten, making this test invaluable for diagnosing gluten-sensitive enteropathy and related conditions.

What Does This Test Measure?

This specialized diagnostic test detects and quantifies IgA antibodies directed against endomysial antigens, primarily tissue transglutaminase (tTG). The test utilizes immunofluorescence technology to visualize antibody binding patterns in various dilutions, providing:

  • Detection of autoimmune response to gluten proteins
  • Quantification of antibody levels through serial dilutions
  • Assessment of intestinal mucosal immune activity
  • Identification of celiac disease-specific antibody patterns

Who Should Consider This Test?

This test is recommended for individuals experiencing symptoms suggestive of celiac disease or gluten sensitivity. Key indications include:

Symptoms and Clinical Presentations

  • Chronic diarrhea or constipation lasting more than 4 weeks
  • Unexplained weight loss despite adequate calorie intake
  • Abdominal bloating, pain, or discomfort after meals
  • Iron-deficiency anemia unresponsive to iron supplementation
  • Fatigue, weakness, or general malaise
  • Dermatitis herpetiformis (skin rash associated with celiac disease)
  • Dental enamel defects or recurrent mouth ulcers
  • Elevated liver enzymes without clear cause
  • Family history of celiac disease or autoimmune disorders

Benefits of Endomysial Antibody Testing

Choosing the Endomysial Antibody IgA IFA in Dilutions Test offers numerous advantages for comprehensive gastrointestinal health assessment:

Diagnostic Precision

  • High specificity for celiac disease diagnosis (over 95%)
  • Excellent correlation with intestinal biopsy findings
  • Ability to monitor disease activity and dietary compliance
  • Early detection of subclinical or silent celiac disease

Clinical Management Advantages

  • Guides appropriate gluten-free diet implementation
  • Helps prevent long-term complications like osteoporosis
  • Supports nutritional deficiency identification and management
  • Facilitates screening of at-risk family members

Understanding Your Test Results

Interpreting Endomysial Antibody results requires professional medical expertise, but general guidance includes:

Positive Results

A positive test indicates the presence of IgA antibodies against endomysial antigens, strongly suggesting active celiac disease. The dilution level at which antibodies remain detectable provides information about antibody concentration and disease activity. Higher titers typically correlate with more extensive intestinal damage.

Negative Results

Negative results generally rule out active celiac disease with high probability. However, false negatives can occur in individuals with selective IgA deficiency, requiring additional testing with IgG-based assays in such cases.

Borderline or Equivocal Results

Intermediate results may warrant repeat testing, additional serological markers, or consideration of small intestinal biopsy for definitive diagnosis.

Test Pricing and Availability

Test Name Discount Price Regular Price
Endomysial Antibody IgA IFA in Dilutions Test $126 USD $188 USD

Testing Process Details

  • Sample Type: 3 mL (1.5 mL minimum) serum from 1 SST tube
  • Shipping Requirements: Refrigerated or frozen transport
  • Turnaround Time: Sample accepted daily by 11 AM, results next day
  • Pre-test Instructions: Overnight fasting is preferred for optimal results

Nationwide Testing Availability

GGC DNA maintains comprehensive testing facilities across the United States, with specialized centers in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network ensures convenient access to advanced diagnostic services regardless of your location.

Book Your Test Today

Take control of your gastrointestinal health with our specialized Endomysial Antibody testing. Our expert team of gastroenterologists and immunopathology specialists are ready to provide comprehensive care and accurate diagnosis.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your appointment or discuss your testing needs with our medical professionals.

Early detection and proper management of celiac disease can significantly improve quality of life and prevent serious complications. Trust GGC DNA for reliable, accurate diagnostic testing backed by cutting-edge technology and medical expertise.